Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Canadian Liver Journal|November 28, 2025
Long-term clinical outcomes in lysosomal acid lipase deficiency: Fibrosis regression with sebelipase alfa therapyMaria MacDonald, Grace Park, Scott Bray, et al.Antibiotics (Basel, Switzerland)|May 30, 2020
Iron Chelation in Murine Models of Systemic Inflammation Induced by Gram-Positive and Gram-Negative ToxinsDanielle Fokam, Kayle Dickson, Kiyana Kamali, et al.Biomedicines|July 27, 2024
The Hydroxypyridinone Iron Chelator DIBI Reduces Bacterial Load and Inflammation in Experimental Lung InfectionXiyang Zhang, Rhea Nickerson, Lauren Burton, et al.The Journal of Infectious Diseases|January 17, 2019
Rat Hepatitis E Virus Linked to Severe Acute Hepatitis in an Immunocompetent PatientAnton Andonov, Mark Robbins, Jamie Borlang, et al.Clinical Transplantation|January 10, 2018
The impact of donor liver allograft fibrosis on patients undergoing liver transplantationVikram Wadhera, Norifumi Harimoto, Nir Lubezky, et al.European Journal of Radiology Open|August 2, 2017
Feasibility and reproducibility of liver surface nodularity quantification for the assessment of liver cirrhosis using CT and MRIGrace C Lo, Cecilia Besa, Michael J King, et al.Journal of Magnetic Resonance Imaging : JMRI|March 14, 2022
Prospective Evaluation of Virtual MR Elastography With Diffusion-Weighted Imaging in Subjects With Nonalcoholic Fatty Liver DiseaseElyisha Hanniman, Andreu F Costa, Chris V Bowen, et al.Journal of Magnetic Resonance Imaging : JMRI|December 2, 2017
Detection of liver fibrosis using qualitative and quantitative MR elastography compared to liver surface nodularity measurement, gadoxetic acid uptake, and serum markersCecilia Besa, Mathilde Wagner, Grace Lo, et al.Journal of Hepatology|August 22, 2017
Evaluation of HCC response to locoregional therapy: Validation of MRI-based response criteria versus explant pathologySonja Gordic, Idoia Corcuera-Solano, Ashley Stueck, et al.Journal of Hepatology|January 28, 2017
Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entityAgrin Moeini, Daniela Sia, Zhongyang Zhang, et al.Pageof 3